Global Asthma Competitive Landscape Report 2023: Comprehensive Insights on 110+ Companies and 125+ Drugs
28 avr. 2023 07h03 HE
|
Research and Markets
Dublin, April 28, 2023 (GLOBE NEWSWIRE) -- The "Asthma - Competitive landscape, 2023" report has been added to ResearchAndMarkets.com's offering.This "Asthma- Competitive landscape, 2023" report...
Global Asthma Drugs Market Forecast to 2028 - Opportunities with Commercialization of Biologics
21 juin 2022 05h38 HE
|
Research and Markets
Dublin, June 21, 2022 (GLOBE NEWSWIRE) -- The "Global Asthma Drugs Market Forecast to 2028 - COVID-19 Impact and Global Analysis by Medications, Route of Administration, and Distribution Channels"...
New Asthma Drug Nucala (Mepolizamab) Available Now to Treat Severe Asthma
20 janv. 2017 03h00 HE
|
Allergy Partners
ASHEVILLE, N.C., Jan. 20, 2017 (GLOBE NEWSWIRE) -- Earlier this year, the FDA has approved Nucala as add on therapy for maintenance treatment in patients with severe eosinophilic asthma in patients...